Eli Lilly and Company (NYSE: LLY) has agreed to acquire Merida Biosciences, Inc., a biotechnology company developing treatments for autoimmune ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions